C H Shackleton

668 total citations
12 papers, 541 citations indexed

About

C H Shackleton is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, C H Shackleton has authored 12 papers receiving a total of 541 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Endocrinology, Diabetes and Metabolism, 3 papers in Surgery and 2 papers in Molecular Biology. Recurrent topics in C H Shackleton's work include Hormonal Regulation and Hypertension (4 papers), Adrenal Hormones and Disorders (3 papers) and Cholesterol and Lipid Metabolism (2 papers). C H Shackleton is often cited by papers focused on Hormonal Regulation and Hypertension (4 papers), Adrenal Hormones and Disorders (3 papers) and Cholesterol and Lipid Metabolism (2 papers). C H Shackleton collaborates with scholars based in United States, United Kingdom and Australia. C H Shackleton's co-authors include Paul M. Stewart, Domhnall O’Halloran, G Holder, BR Walker, Esther Roitman, M. Palermo, George Phillipov, Richard B. Hochberg, Janice M. Larner and Mary Ann O’Riordan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

C H Shackleton

12 papers receiving 525 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C H Shackleton United States 11 288 164 134 81 80 12 541
W. Staib Germany 12 202 0.7× 231 1.4× 60 0.4× 90 1.1× 109 1.4× 129 640
Lisa Kurland Sweden 15 389 1.4× 191 1.2× 62 0.5× 207 2.6× 72 0.9× 20 705
Jill Schneider United States 8 439 1.5× 190 1.2× 91 0.7× 49 0.6× 185 2.3× 10 696
Shaheen Khadem United States 7 201 0.7× 372 2.3× 254 1.9× 101 1.2× 60 0.8× 7 829
George J. Miller United Kingdom 16 240 0.8× 206 1.3× 145 1.1× 22 0.3× 326 4.1× 17 826
Keith Tanner United States 9 189 0.7× 190 1.2× 66 0.5× 43 0.5× 58 0.7× 14 563
Leyla C. Ramirez France 9 642 2.2× 332 2.0× 126 0.9× 128 1.6× 72 0.9× 23 805
H Oftebro Norway 18 365 1.3× 258 1.6× 286 2.1× 134 1.7× 70 0.9× 29 965
В. П. Иванов Russia 16 102 0.4× 169 1.0× 41 0.3× 55 0.7× 134 1.7× 45 514
Sonoko Masuda Japan 13 165 0.6× 128 0.8× 32 0.2× 39 0.5× 150 1.9× 28 747

Countries citing papers authored by C H Shackleton

Since Specialization
Citations

This map shows the geographic impact of C H Shackleton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C H Shackleton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C H Shackleton more than expected).

Fields of papers citing papers by C H Shackleton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C H Shackleton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C H Shackleton. The network helps show where C H Shackleton may publish in the future.

Co-authorship network of co-authors of C H Shackleton

This figure shows the co-authorship network connecting the top 25 collaborators of C H Shackleton. A scholar is included among the top collaborators of C H Shackleton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C H Shackleton. C H Shackleton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
2.
Shackleton, C H. (1999). Neonatal urinary steroids in Smith-Lemli-Opitz syndrome associated with 7-dehydrocholesterol reductase deficiency. Steroids. 64(7). 481–490. 41 indexed citations
3.
Santner, Steven J., et al.. (1999). Comparative Rates of Androgen Production and Metabolism in Caucasian and Chinese Subjects. The Journal of Urology. 161(4). 1386–1387. 14 indexed citations
4.
Bearer, Cynthia F., et al.. (1997). Maternal tobacco smoke exposure and persistent pulmonary hypertension of the newborn.. Environmental Health Perspectives. 105(2). 202–206. 61 indexed citations
5.
Phillipov, George, M. Palermo, & C H Shackleton. (1996). Apparent cortisone reductase deficiency: a unique form of hypercortisolism.. The Journal of Clinical Endocrinology & Metabolism. 81(11). 3855–3860. 61 indexed citations
7.
Stewart, Paul M., BR Walker, G Holder, Domhnall O’Halloran, & C H Shackleton. (1995). 11 beta-Hydroxysteroid dehydrogenase activity in Cushing's syndrome: explaining the mineralocorticoid excess state of the ectopic adrenocorticotropin syndrome.. The Journal of Clinical Endocrinology & Metabolism. 80(12). 3617–3620. 117 indexed citations
8.
Shet, Manjunath S., C. Fisher, Michael P. Arlotto, et al.. (1994). Purification and Enzymatic Properties of a Recombinant Fusion Protein Expressed in Escherichia coli Containing the Domains of Bovine P450 17A and Rat NADPH-P450 Reductase. Archives of Biochemistry and Biophysics. 311(2). 402–417. 62 indexed citations
9.
10.
Larner, Janice M., C H Shackleton, Esther Roitman, P E Schwartz, & Richard B. Hochberg. (1992). Measurement of estradiol-17-fatty acid esters in human tissues.. The Journal of Clinical Endocrinology & Metabolism. 75(1). 195–200. 46 indexed citations
12.
Trant, John M., Matthew C. Lorence, Eric F. Johnson, et al.. (1990). Characterization of the steroid-metabolizing capacity of the hepatic cytochrome P450IIC5 expressed in COS-1 cells: 3 beta-hydroxysteroid dehydrogenase/delta 5----4 isomerase type activity.. Proceedings of the National Academy of Sciences. 87(24). 9756–9760. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026